Skip to main content
. 2018 Apr 2;98(6):1629–1636. doi: 10.4269/ajtmh.17-0936

Table 1.

Patients’ baseline sociodemographic and clinical characteristics

Variable Mean ± SD No. (%)
Gender
 Female 239 (55.8)
 Male 189 (44.2)
Age (years) 30.7 ± 14.35
 10–20 91 (21.3)
 21–40 238 (55.6)
 41–60 77 (18.0)
 >60 22 (6.1)
Weight (kg) 44.9 ± 9.87
 20–40 150 (35.0)
 41–60 252 (58.9)
 >60 26 (6.1)
Residence
 Rural 231 (54.0)
 Urban 197 (46.0)
Marital status
 Single 198 (46.3)
 Married 208 (48.6)
 Widow 22 (5.1)
Smoking
 Nonsmokers 365 (85.3)
 Active + ex-smokers 53 (14.7)
Previous TB treatment
 No 49 (11.4)
 Yes 379 (88.6)
Previous treatment regimen
 New patients 49 (11.4)
 Category I* 185 (43.2)
 Category II 162 (37.9)
 Unknown 32 (7.5)
History of SLD use
 No 361 (84.3)
 Yes 35 (8.2)
 Unknown 32 (7.5)
Sputum smear grading at baseline visit
 Negative 32 (7.5)
 Scanty (1–9 AFB/100 HPF) 12 (2.8)
 +1 (10–99 AFB/100 HPF) 133 (31.1)
 +2 (1–9 AFB/HPF) 127 (29.7)
 +3 (> 9 AFB/HPF) 124 (29.0)
Chest X-ray at baseline visit
 No cavitation 283 (66.1)
 Cavitation 145 (33.9)
Comorbidity
 No 368 (66.0)
 Yes 60 (14.0)
Types of comorbidities
 Diabetes mellitus 20
 Hypertension 24
 Hepatitis 6
 HIV-AIDS 1
 Others 9

AFB = acid fast bacilli; AIDS = acquired immune deficiency syndrome; HIV = human immunodeficiency virus; HPF = high power field; SD = standard deviation; SLD = second-line anti-TB drugs; TB = tuberculosis.

*

2RHZE + 4RH.

3RHZES + 5RHE.